Sativa Wellness Group Inc (LON:SWEL) said it has submitted its novel food application for validation to the UK’s Food Standards Agency (FSA) ahead of the March 31 deadline as part of what it said is its “commitment to continually deliver the highest level of regulatory compliance and product quality”.
The cannabidiol (CBD) specialist said the submission, led by the life sciences regulatory and quality compliance consultancy Global Regulatory Services and supported by its in-house team of scientists and quality and compliance professionals, incorporates an “extensive array of products” under its Goodbody brand including oil-based food supplements, gummies, soft gel capsules and sports recovery gels, as well as wholesale bulk CBD ingredients.
Sativa added that a landmark toxicology study had provided the necessary safety data required by the FSA, and that it also plans to submit the same application to the European Food Safety Authority (EU FSA) once it has collated the pre-requisite consumer product stability, toxicology and genotox data.
“This is a significant milestone for the company. The CBD market is likely to consolidate around the major players that put product quality and regulatory compliance at the forefront. Sales channels in the UK will open up and smaller players will likely fall away”, Sativa’s executive chairman Geremy Thomas said in a statement.